Literature DB >> 17606919

Control of specificity and magnitude of NF-kappa B and STAT1-mediated gene activation through PIASy and PIAS1 cooperation.

Samuel Tahk1, Bin Liu, Vasili Chernishof, Kelly A Wong, Hong Wu, Ke Shuai.   

Abstract

NF-kappaB and STATs regulate multiple cellular processes through the transcriptional activation of genes with diversified functions. Although the molecular mechanisms that can turn on/off the overall NF-kappaB/STAT signaling have been extensively studied, how NF-kappaB/STAT-target genes can be differentially regulated is poorly understood. Here we report that PIASy, a member of the PIAS (for protein inhibitor of activated STAT) protein family, is a physiologically important transcriptional repressor of NF-kappaB and STAT1. Piasy deletion in dendritic cells resulted in enhanced expression of a subset of NF-kappaB and STAT1-dependent genes in response to LPS or IFN-gamma treatment, respectively. Consistently, Piasy null mice are hypersensitive to the LPS-induced endotoxic shock. Furthermore, PIASy and PIAS1 display specific as well as redundant effects on the regulation of NF-kappaB/STAT1 signaling. Pias1-/-Piasy-/- embryos died before day 11.5. The disruption of one allele of Pias1 in the Piasy-/- background significantly enhanced the effect of Piasy deletion on the transcriptional induction of NF-kappaB/STAT1-dependent genes, and vice versa. Our results demonstrate that PIASy cooperates with PIAS1 to regulate the specificity and magnitude of NF-kappaB/STAT1-mediated gene activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17606919      PMCID: PMC1913887          DOI: 10.1073/pnas.0701877104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

Review 1.  Regulation of JAK-STAT signalling in the immune system.

Authors:  Ke Shuai; Bin Liu
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

Review 2.  Rel/NF-kappaB/IkappaB proteins and cancer.

Authors:  T D Gilmore; M Koedood; K A Piffat; D W White
Journal:  Oncogene       Date:  1996-10-03       Impact factor: 9.867

Review 3.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

4.  Specific inhibition of Stat3 signal transduction by PIAS3.

Authors:  C D Chung; J Liao; B Liu; X Rao; P Jay; P Berta; K Shuai
Journal:  Science       Date:  1997-12-05       Impact factor: 47.728

Review 5.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

6.  PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity.

Authors:  Bin Liu; Sheldon Mink; Kelly A Wong; Natalie Stein; Crescent Getman; Paul W Dempsey; Hong Wu; Ke Shuai
Journal:  Nat Immunol       Date:  2004-08-15       Impact factor: 25.606

7.  A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma.

Authors:  K Shuai; G R Stark; I M Kerr; J E Darnell
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

Review 8.  Dysfunctional cytokine receptor signaling in severe combined immunodeficiency.

Authors:  W J Leonard
Journal:  J Investig Med       Date:  1996-08       Impact factor: 2.895

9.  Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT.

Authors:  Jianyin Long; Isao Matsuura; Dongming He; Guannan Wang; Ke Shuai; Fang Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-06       Impact factor: 11.205

10.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  44 in total

Review 1.  The nuclear factor NF-kappaB pathway in inflammation.

Authors:  Toby Lawrence
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-07       Impact factor: 10.005

2.  PIASy inhibits virus-induced and interferon-stimulated transcription through distinct mechanisms.

Authors:  Toru Kubota; Mayumi Matsuoka; Songxiao Xu; Noriyuki Otsuki; Makoto Takeda; Atsushi Kato; Keiko Ozato
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

3.  Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression.

Authors:  Toru Kubota; Mayumi Matsuoka; Tsung-Hsien Chang; Prafullakumar Tailor; Tsuguo Sasaki; Masato Tashiro; Atsushi Kato; Keiko Ozato
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

Review 4.  PIAS proteins: pleiotropic interactors associated with SUMO.

Authors:  Miia M Rytinki; Sanna Kaikkonen; Petri Pehkonen; Tiina Jääskeläinen; Jorma J Palvimo
Journal:  Cell Mol Life Sci       Date:  2009-06-13       Impact factor: 9.261

Review 5.  Return to homeostasis: downregulation of NF-κB responses.

Authors:  Jürgen Ruland
Journal:  Nat Immunol       Date:  2011-06-19       Impact factor: 25.606

6.  Allo-antigen stimulated CD8+ T-cells suppress NF-κB and Ets-1 DNA binding activity, and inhibit phosphorylated NF-κB p65 nuclear localization in CD4+ T-cells.

Authors:  Ryuichi Nagashima; Fumitaka Kawakami; Shinichiro Takahashi; Fumiya Obata; Makoto Kubo
Journal:  Viral Immunol       Date:  2014-05-20       Impact factor: 2.257

Review 7.  Regulation of NF-κB by TNF family cytokines.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Semin Immunol       Date:  2014-06-21       Impact factor: 11.130

8.  PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15.

Authors:  Neale T Hanke; Collin J LaCasse; Claire B Larmonier; Darya Alizadeh; Malika Trad; Nona Janikashvili; Bernard Bonnotte; Emmanuel Katsanis; Nicolas Larmonier
Journal:  Eur J Immunol       Date:  2014-05-23       Impact factor: 5.532

9.  Dietary phenethylisothiocyanate attenuates bowel inflammation in mice.

Authors:  Moul Dey; Peter Kuhn; David Ribnicky; Vummidigiridhar Premkumar; Kenneth Reuhl; Ilya Raskin
Journal:  BMC Chem Biol       Date:  2010-04-27

Review 10.  SUMO--a post-translational modification with therapeutic potential?

Authors:  Chang-Hoon Woo; Jun-Ichi Abe
Journal:  Curr Opin Pharmacol       Date:  2010-01-14       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.